Placental signaling factors come from six distinct regions. What the decidua, villous placenta, cord blood, Wharton's jelly, amnion and chorion each carry.
The placenta is the only organ a human body builds from scratch and then discards on purpose. It exists for the length of a pregnancy, does an extraordinary amount of work in that window, and is then delivered and, in most hospitals, thrown away.
It is also not a single tissue. Underneath the one word sits a set of anatomically distinct regions with separate jobs: holding an implantation, running an exchange surface, cushioning a cord, sealing a membrane, building a blood supply. Different jobs require different instructions, so each region carries a different set of signalling proteins.
Ultra RSF (Regenerative Signaling Factors) is sourced from all six of those regions rather than one. Below, each is taken in turn: what it does during a pregnancy, and what that implies about the signalling vocabulary it contributes.
Most preparations in this category begin from one tissue. Stem-cell products are usually expanded from Wharton's jelly or cord blood; exosome products are collected from a single cultured cell population. Either way, the range of signals available is the range that one source happens to produce.
A concentrate drawing from six regions carries a wider range than that. It is a compositional statement and should be read as nothing more — wider input is not a synonym for better outcome, and the head-to-head trials that could turn one into the other do not exist. What follows describes the biology of each region, hedged wherever the biology is not settled. The same six are set out on the treatment page.
The decidua is the maternal-side lining that a pregnancy implants into. Its work begins before almost anything else: accepting an implantation, then sustaining an arrangement in which the mother's immune system tolerates tissue that is genetically half foreign to it, without standing down its guard against everything else.
That is a remarkable piece of immune engineering, and it is conducted entirely in signals. What the decidua contributes to the concentrate is weighted accordingly, toward implantation signalling and immune tolerance — the vocabulary of persuading an immune system to modulate rather than attack. Immune balance is one of the three processes regenerative signaling factors are understood to act on.
The villous placenta is where maternal and fetal circulations come close enough to trade. Oxygen and nutrients cross one way, waste the other, across a surface folded into villi so that the available area is enormous relative to the space it occupies.
An exchange surface working at that intensity has to be built, fed and continuously maintained, which puts growth-factor transfer and vascular signalling at the center of what happens there. Those are the cues this region brings: the ones associated with nutrient and gas transfer, and with keeping a metabolically demanding tissue supplied.
Cord blood is the blood held in the umbilical vessels at delivery. It is by some distance the best-known part of the placenta, largely because of the cord-blood banking industry, and it is the source most single-region preparations start from.
What it carries is circulating factors and progenitor signalling — the soluble messages moving through fetal circulation rather than the fixed instructions held in a structural tissue. Inside a six-region concentrate it is one input among several rather than the whole account, which is the substantive difference between this and a cord-blood-derived product.
Wharton's jelly is the gelatinous matrix surrounding and protecting the umbilical vessels. Its function is mechanical: keeping a cord from kinking or compressing while a fetus moves. That is a load-bearing job performed by a substance with almost nothing rigid in it.
It manages the job through matrix, rich in hyaluronic acid and carrying collagen cues throughout. That makes it the region most associated with structural and matrix signalling — the instructions relevant to how tissue is organised rather than how inflamed it is. It is also, not coincidentally, the region most single-tissue stem-cell preparations are expanded from.
The amnion is the inner membrane, in direct contact with amniotic fluid. It is a barrier in the strictest sense of the word: it has to hold, stay sealed, and stay quiet. An inflamed membrane in that position would be a serious problem rather than a nuisance.
Its contribution is therefore barrier and anti-inflammatory membrane signalling: the cues associated with sealing an epithelial surface and keeping the tissue beneath it from remaining provoked. Barrier integrity is one of the mechanisms most often described for this class of preparation, and the amnion is where a good deal of that vocabulary comes from.
The chorion is the outer membrane, sitting between the amnion and the maternal tissue. It is the vascular layer of the membrane pair, and the one involved in remodelling as a pregnancy grows and the structures around it have to change shape without failing.
Vascular and remodelling signals are its contribution. Remodelling is worth pausing on, because it is the least intuitive part of repair: laying down new tissue is the middle of the process, not the end, and whether that tissue is organised into something durable gets decided afterwards. The repair, rebuild and remodel arc follows the same logic across a course of treatment.
| Region | Its job during pregnancy | Signalling it carries |
|---|---|---|
| Decidua | Maternal-side lining that accepts and holds an implantation | Implantation signalling and immune tolerance |
| Villous placenta | The exchange surface between two circulations | Nutrient, gas and growth-factor transfer |
| Umbilical cord blood | Blood moving through the cord vessels | Circulating factors and progenitor signalling |
| Wharton's jelly | Protective matrix cushioning the cord vessels | Hyaluronic acid and collagen matrix cues |
| Amnion | Inner membrane holding a sealed, quiet barrier | Barrier and anti-inflammatory membrane signalling |
| Chorion | Outer membrane carrying vasculature as the pregnancy grows | Vascular and remodelling signals |
The decidua, the villous placenta, umbilical cord blood, Wharton's jelly, the amnion and the chorion. Each performs a different function during pregnancy and therefore releases a different profile of signalling proteins.
Each region carries a different signalling vocabulary, so a six-region concentrate contains a broader range of proteins and growth factors than a single-region extract. That describes the breadth of the input rather than the clinical outcome.
No. Ultra RSF is acellular, containing no living cells and no DNA or RNA. Stem-cell preparations are living cells carrying donor genetic material, which is a materially different thing to receive.
No procedure is performed on a donor to obtain this material, which is one way it differs from an autologous stem-cell preparation. Donor material is screened under 21 CFR 1271.55 before any processing begins.
It carries its own profile, weighted toward structural and matrix cues, because that is its function during pregnancy. It does not carry the immune-tolerance signalling of the decidua or the vascular signalling of the chorion, which is the argument for drawing from more than one region.
This article is general health information, not medical advice, and does not create a physician–patient relationship. It describes mechanisms reported in the literature rather than guaranteed outcomes; individual response varies. Regen MDs provides you an alternative to your current care, and is complementary to your guideline-based medical care. Ultra RSF (Regenerative Signaling Factors) is not a stem-cell therapy. Talk to a licensed clinician before starting, stopping, or changing any treatment.
The reason so much regenerative research points away from the cells themselves, and what a physician is actually giving when the vial says signaling factors.
Five processing steps stand between placental tissue and a sealed vial of freeze-dried protein. Each one removes, checks or preserves something specific.
Three preparations, three different contents — and a market that blurs them on purpose. A composition-by-composition comparison, with no outcome claims attached.
Thirty minutes with one of our physicians — no cost, no obligation — to review your history and set out the options honestly.